SEC Form D filing

Silo Pharma, Inc., 2026-07-14

An SEC Form D private-offering notice from Sarasota, FL, a $4,000,015 filer-stated offering target in Biotech. Filed 2026-07-14. The source filing is one click away. For companies that filed this week, open the live feed.

What this filing says

Silo Pharma, Inc. site↗ Verified via SEC Form D

Publicly traded developmental stage biopharmaceutical company developing therapeutics for PTSD, stress induced anxiety, fibromyalgia and other CNS conditions, including an intranasal PTSD treatment and a ketamine loaded implant for chronic pain.

Filed 2026-07-14Filed to raise $4,000,015First money in 2026-07-09Raised so far $4,000,015HQ (as filed) Sarasota, FLSector Biotech web-verified against the company’s own siteStage (inferred) SeedCall status Call-ready
Source linked the Form D on EDGAR↗Website verified silopharma.com↗Named in the filing 5 executives & directors
Open this row on the live feed →More new filings in Florida →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.

Other Form D filings from the same week

each with its own page and its own EDGAR source